Leo Pharma recalls

Leo Pharma appears in 3 official U.S. recall notices indexed by RecallRadar, most recently on 2026-03-04.

Company names are normalized from agency data (legal suffixes removed), so related firms may appear under separate pages.

• Adbry, (tralokinumab-ldrm) injection, 300 mg/2mL, Packaged as a) 1 x Single dose Autoinjector, SAMPLE NOT FOR SALE, NDC 50222-350-91
  FDA Drug · Class II · 2026-03-04 · Leo Pharma
• Calcipotriene Cream 0.0005%, packaged in a) 60g tube, (NDC 66993-877-61), b) 120g tube (NDC 66993-877-78), Rx Only, Manufactured by: LEO Ph…
  FDA Drug · Class II · 2017-03-15 · Leo Pharma
• Taclonex (calcipotriene and betamethasone dipropionate) Topical Suspension, 0.005%/0.064%, packaged in (a) 60 g (NDC 50222-501-06), and (b)…
  FDA Drug · Class III · 2017-02-22 · Leo Pharma